SCHEMBL3586812

SCHEMBL3586812

O=C(O)c1c[nH]c(-c2ccc(C(F)(F)F)cc2)nc1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
ALOX12 P18054 1/20 0.47
KMT2A Q03164 1/20 0.47
TNKS O95271 3/20 0.44
TNKS2 Q9H2K2 3/20 0.44
WNT3A P56704 2/20 0.44
COMT P21964 1/20 0.43
PARP1 P09874 3/20 0.42
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
GFER P55789 1/20 0.41
TYMP P19971 1/20 0.40
CYP2C8 P10632 1/20 0.40
NOTUM Q6P988 1/20 0.39
DGAT1 O75907 1/20 0.39
SOAT1 P35610 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4376723 0.81 KDM4E (0.49) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL3536068 0.81 F7 (0.44) ALDH1A1HPGDTNKSTNKS2PARP1
SCHEMBL15167516 0.81 GFER (0.44) TNKSTNKS2WNT3ACOMTPARP1
SCHEMBL5867336 0.73 KDM4E (0.43) ALDH1A1HPGDMEN1CYP1A2ALOX12
SCHEMBL1336674 0.73 GFER (0.45) TNKSTNKS2WNT3ACOMTPARP1
SCHEMBL8797359 0.72 GFER (0.50) HPGDTNKSTNKS2WNT3ACOMT
SCHEMBL3586816 0.71 COMT (0.68) TNKSTNKS2WNT3ACOMTPARP1
SCHEMBL7248333 0.71 GFER (0.46) TNKSTNKS2WNT3ACOMTPARP1
SCHEMBL11161159 0.71 ALDH1A1 (0.49) ALDH1A1HPGDMEN1CYP1A2ALOX12
SCHEMBL28157997 0.70 CFTR (0.43) ALDH1A1TNKSTNKS2COMTPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144765-A1 5,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS HICKEY DEIDRE MARY BERNADETTE 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144765-A1 5,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS PLA2G4A, PLA2G4B, PLA2G1B ALDH1A1 623/4885HPGD 471/4885MEN1 2772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.